ARCHIVES

Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013

New Mexico, Michigan Win Saturation Implementation Contracts

June 6, 1975

Mark Israel To Direct Norris Cotton Center

October 19, 2001

NIH Programs: Varmus Appoints 20 To Council of Public Representatives

April 30, 1999

Commercial Firms Get Foot In The Door With CREG, But Won’t Be Permitted To Make Money On Grants

January 10, 1975

Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends

December 9, 1988